Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 222 entries
Sorted by: Best Match Show Resources per page
Competition: good news and bad news.

Inquiry : a journal of medical care organization, provision and financing

Tresnowski BR.
PMID: 6226604
Inquiry. 1983;20(3):199-200.

No abstract available.

Reconciling the antitrust laws and the health care laws: a step backward?.

Journal of the Medical Association of Georgia

Berg RN.
PMID: 7276770
J Med Assoc Ga. 1981 Aug;70(8):577-9.

No abstract available.

[The first evaluation of the British health care reform. Lessons to be learnt in relation to Swedish development].

Lakartidningen

Bergman SE.
PMID: 7853940
Lakartidningen. 1995 Feb 08;92(6):540-2.

No abstract available.

Health care and not enough dollars.

The Western journal of medicine

Watts MS.
PMID: 6730472
West J Med. 1984 Feb;140(2):274-5.

No abstract available.

"Procompetition" and the continuing struggle to contain health-care costs.

American journal of hospital pharmacy

Enright SM.
PMID: 6829583
Am J Hosp Pharm. 1983 Feb;40(2):282-6.

Various proposals designed to increase competitive forces in the health-care services economy are discussed. Two concepts inherent in market-oriented strategies for containing health-care costs--cost sharing and fixed-dollar subsidies--are defined. Among the strategies for increasing market forces in health care...

Marketplace choice as deterrent to government price controls.

IMJ. Illinois medical journal

[No authors listed]
PMID: 45800
IMJ Ill Med J. 1978 Oct;154(4):192.

No abstract available.

Toward a national health care policy in the United States.

Southern medical journal

Auerbach PS.
PMID: 2814626
South Med J. 1989 Nov;82(11):1389-96. doi: 10.1097/00007611-198911000-00012.

No abstract available.

Physician responses to competition. AMA Center for Health Policy Research.

Connecticut medicine

[No authors listed]
PMID: 6697720
Conn Med. 1984 Feb;48(2):115-6.

No abstract available.

Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.

Expert review of pharmacoeconomics & outcomes research

Dierks RM, Bruyère O, Reginster JY, Richy FF.
PMID: 27653356
Expert Rev Pharmacoecon Outcomes Res. 2016 Oct;16(5):571-578. doi: 10.1080/14737167.2016.1239534. Epub 2016 Oct 04.

INTRODUCTION: Technological innovations, new regulations, increasing costs of drug productions and new demands are only few key drivers of a projected alternation in the pharmaceutical industry. The purpose of this review is to understand the macro economic factors responsible...

Practitioner Application.

Journal of healthcare management / American College of Healthcare Executives

Sullivan S.
PMID: 26904775
J Healthc Manag. 2016 Jan-Feb;61(1):26-7.

No abstract available.

Multiple Openings and Competitiveness of Forward Markets: Experimental Evidence.

PloS one

Ferreira JL, Kujal P, Rassenti S.
PMID: 27442516
PLoS One. 2016 Jul 21;11(7):e0158098. doi: 10.1371/journal.pone.0158098. eCollection 2016.

We test the competition enhancing effect of selling forward in experimental Cournot duopoly and quadropoly with multiple forward markets. We find that two forward periods yields competitive outcomes and that the results are very close to the predicted theoretical...

What happened to the innovation and competition Zarxio was supposed to spark?.

Modern healthcare

Johnson SR.
PMID: 27382872
Mod Healthc. 2016 Mar 28;46(13):11.

No abstract available.

Showing 1 to 12 of 222 entries